Can a vaccine stop precancerous lesions from returning?
NCT ID NCT07431502
Summary
This study aims to find out if the 9-valent HPV vaccine can prevent high-grade, precancerous lesions from coming back after they have been treated. It will involve about 984 patients aged 18-55 who have recently been treated for these HPV-related lesions. Participants will be randomly assigned to receive either the real vaccine or a placebo shot to compare the recurrence rates.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH PRIMARY HPV HIGH-GRADE SQUAMOUS INTRA-EPITHELIAL LESIONS (HSIL) AT VULVAR SITE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.